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Oxalate toxicity in LLC-PK1 cells: Role of free radicals. Oxalate, the
most common constituent of kidney stones, is an end product of metab-
olism that is excreted by the kidney. During excretion, oxalate is trans-
ported by a variety of transport systems and accumulates in renal tubular
cells. This process has been considered benign; however, recent studies on
LLC-PK1 cells suggested that high concentrations of oxalate are toxic,
inducing morphological alterations, increases in membrane permeability
to vital dyes and loss of cells from the monolayer cultures. The present
studies examined the basis for oxalate toxicity, focusing on the possibility
that oxalate exposure might increase the production/availability of free
radicals in LLC-PK1 cells. Free radical production was monitored in two
ways, by monitoring the reduction of nitroblue tetrazolium to a blue
reaction product and by following the conversion of dihydrorhodamine
123 (DHR) to its fluorescent derivative, rhodamine 123. Such studies
demonstrated that oxalate induces a concentration-dependent increase in
dye conversion by a process that is sensitive to free radical scavengers.
Specifically, addition of catalase or superoxide dismutase blocked the
oxalate-induced changes in dye fluorescence/absorbance. Addition of
thsc free radical scavengers also prevented the oxalate-induced loss of
membrane integrity in LLC-PK1 cells. Thus it seems likely that free
radicals are responsible for oxalate toxicity. The levels of oxalate that
induced toxicity in LLC-PK1 cells (350 .rM) was only slightly higher than
would be expected to occur in the renal cortex. These considerations
suggest that hyperoxaluria may contribute to the progression of renal
injury in several forms of renal disease.
Oxalate, the most common constituent of kidney stones, is a
simple dicarboxylic acid that is produced as a byproduct of a
number of metabolic pathways [1]. This byproduct cannot be
processed further in man and is excreted by the kidney. Studies of
renal oxalate handling have shown that oxalate is freely filtered at
the glomerulus and undergoes both reabsorption and secretion in
the proximal tubules [2], with secretion predominating under
normal physiological conditions [3, 4]. Removal of oxalate in the
kidney is facilitated by a variety of transport systems at the apical
and basolateral surfaces of both proximal [5—7] and distal [8]
tubular cells; in the course of vectorial transport, oxalate accumu-
lates intracellularly [9]. This accumulation has been considered
benign, despite the fact that oxalate can alter the activity of a
number of enzymes (lactate dehydrogenase, malate dehydroge-
nase, pyruvate kinase, etc., see [10]). Indeed, the only pathologies
that have been attributed to oxalate (oxalosis, hyperoxaluria,
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calcium oxalate stone disease) stem from the tendency of this
molecule to form calcium oxalate crystals [11].
Recent studies in our laboratory have suggested that oxalate
may induce additional effects on renal cellular function, however.
Studies using using LLC-PK1 cells, a line of renal epithelial cells
with characteristics of proximal tubular cells [12—14], revealed that
oxalate exerts biphasic, concentration-dependent effects on the
viability and growth of renal epithelial cells, acting as a mitogen at
low concentrations of oxalate [15] and acting as a toxin at high
concentrations [16]. These findings are reminiscent of those seen
in response to oxidant stress in other systems [17, 18]. Thus the
present studies examined the possibility that oxalate may induce a
form of oxidant stress in renal epithelial cells. These studies
demonstrated that oxalate exposure increases the production!
availability of free radicals in LLC-PK1 cells and suggested that
this increase in free radical production is responsible for oxalate
toxicity. The results from these studies suggest possible explana-
tions as to how hyperoxaluria may promote stone disease. They
also suggest a role for oxalate in other forms of renal disease in
which serum oxalate levels are elevated. Preliminary reports of
these findings have been presented [19, 20].
Methods
Cell cultures
LLC-PK1 cells (CRL 1392, American Type Culture Collection)
were used between passages 205 and 240. Aliquots of 1.5 million
cells were grown in Dulbecco's modified Eagle's minimal essential
medium (DMEM) supplemented with 10% fetal bovine serum,
glucose and antibiotics at 37°C, under 5% CO2. Cells were used
three to four days after plating.
DMEM, penicillin and streptomycin were obtained from
GIBCO (Grand Island, NY, USA), fetal bovine serum from
Hyclone Laboratories Inc. (Logan, UT, USA). Formic acid, oxalic
acid, malonic acid, succinic acid, citric acid and urate were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Nitroblue tetrazolium, catalase (from bovine liver, 3100 U!mg),
superoxide dismutase (from bovine kidney, 4950 U!mg), and
hydrogen peroxide (30%) were also purchased from Sigma.
Dihydrorhodamine 123 (DHR 123), ethidium homodimer-1 and
Hoechst 33342 were purchased from Molecular Probes (Eugene,
OR, USA). Stock solutions of DHR 123 (10 mM) were prepared
in dry dimethyl formamide and stored in air tight vials at —20°C.
Stock solutions of ethidium homodimer-1 and Hoechst 33342
were made up as required in incubation buffer. All chemicals were
of the highest grade available. Experiments were conducted in
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either DMEM (buffered with either bicarbonate or HEPES)
supplemented with 0.25% serum or mammalian Kreb's Ringer
(MKR) buffer containing: NaC1 122 mrvi, KCI 3 mi, MgCI2 2.25
mM, HEPES (N-2-hydroxyethyl-piperazine-N'-2-ethane sulfonic
acid) 24 mrvi, NaHCO3 15 mivi, CaC12, 1.8 m, dextrose 10 mM, pH
7.2. Where indicated, sodium oxalate was added at a concentra-
tion of 0.1, 0.2, 0.4, 1.0, 2.0 or 4.0 m (total), which increased the
free oxalate levels to 0.03, 0.07, 0.14, 0.35, 0.75 or 1.6 m, and
increased the relative supersaturation level (RSS) for calcium
oxalate to 2.6, 5.2, 10.3, 24.9, 47.2 or 84.3, respectively. Estimates
of free oxalate and RSS were obtained using the EQUIL program
[21]. Note, however, that these estimates of free oxalate and RSS
do not include possible effects of amino acids in DMEM since the
program does not take these molecules into account.
Monitoring free radical production
Spectrophotometty. To obtain evidence that oxalate increases
the production of free radicals in renal epithelial cells, we
monitored oxalate-induced changes in the reduction of nitroblue
tetrazolium (NBT) as described previously [22]. For these studies
confluent cultures of LLC-PK1 cells in 6 well plates were exposed
for varying periods (0 to 120 mm) to DMEM containing 25 xg/ml
NBT, a dye that reacts with superoxide [23, 24]. Where indicated
oxalate (0 to 4 m total, 0 to 1.6 mrvi free), superoxide dismutase
(500 U/mi) and/or catalase (300 U/mi) were also added. At
predetermined intervals (60, 90, 120 or 240 mm) the medium was
removed and the reaction was halted by the addition of 70%
methanol. The monolayers were washed with four changes of
100% methanol to remove nonreduced NBT, air dried and
solubilized with a mixture of 2 M potassium hydroxide and
dimethyl suifoxide (1:1.167). Samples were then centrifuged four
minutes at 15,000 rpm in a Beckman microfuge and read at 700
nm (density 0D700) using a Beckman DU-7 spectrophotometer
against a blank cuvette containing KOH and DMSO. Optical
densities in treated samples were then normalized to those in
untreated samples in which the optical densitites averaged 0.025
0.005 (means SEM from 20 separate monolayers from 3
separate piatings).
Spectrofluorimetiy. In other experiments, free radical produc-
tion was monitored on-line using dihyrorhodamine 123, a non-
fluorescent compound that is converted to a fluorescent product,
rhodamine 123, by reactive oxygen molecules [25—27]. For such
studies confluent cultures of LLC-PK1 cells (on rectangular 12 X
25 mm coverslips) were removed from their culture medium,
washed once with MKR and transferred to a standard quartz
cuvette containing MKR with 1 to 10 jIM DHR. (Preliminary
studies indicated the importance of short loading times with low
dye concentrations since responses are damped when cells accu-
mulate excess dye). After two minutes exposure to dye-containing
solution, the coverslip was removed, the cuvette was rinsed 3 ><
with MKR and refilled with MKR or DMEM (results were the
same in both buffers; thus results were pooled below). Where
indicated, superoxide dismutase, catalase or citrate were added
along with oxalate. The coverslip was then placed diagonally
across the cuvette, and the fluorescent signal at 540 nm was
detected at right angles to the excitation source (A = 510 nm).
Baseline fluorescence was recorded for a minimum of 10 minutes,
then the effects of various additives (30 jil additions) were
monitored for an additional 10 minutes. Further additions were
made at 10 minutes intervals. The final addition was always 30 jxl
of 0.8 M hydrogen peroxide (a positive control to demonstrate that
cells retained sufficient dye to provide a robust response). All
experiments were conducted at 22 1°C, fluorescence intensity
was recorded each second and the rate of change in fluorescence
was analyzed by linear regression analysis of the last five minutes
of the 10 minutes interval. Each coverslip culture was received a
single treatment; data for each experimental condition reflect
means from nine or more monolayers. Because there was consid-
erable variation among experiments even under basal conditions,
each coverslip served as its own control, and comparisons em-
ployed paired t-tests with a confidence level of 0.025.
Separate studies demonstrated that the rate of dye cleavage was
stable for at least an hour under each of these conditions; thus dye
loss appeared to be minimal. Other studies demonstrated that the
various additives tested (oxalate, catalase, superoxide dismutase,
etc.) exerted no direct effects on dye fluoresecence in the absence
of cells.
Cell viability assay
Ethidium homodimer-1. To determine whether or not free
radicals were responsible for oxalate toxicity, LLC-PK1 cells were
exposed to oxalate for one to four hours in the presence or
absence of extracellular free radical scavengers and stained with
the vital dye ethidium homodimer- 1, a fluorescent vital dye which
is excluded from intact cells [28]. For such studies subconfluent
cultures in 12 well plates were treated for four hours at 37°C in
DMEM with varying concentrations of oxalate (0 to 1 m total, 0
to 350 jIM free). Where indicated, catalase (300 to 500 U/mI, an
enzyme that degrades peroxide to H20), superoxide dismutase
(500 U/ml, an agent that converts superoxide to peroxide and 02),
citrate (1 mM, a naturally occurring compound that limits kidney
stone formation in vivo), desferoxamine mesylate (50 jIM to 20
m, an iron chelator that blocks iron-dependent free radical
generation), or mannitol (10 or 60 m, a hydroxyl radical scav-
enger) were added along with 0.35 m free oxalate. After four
hours the solution was decanted and each well was stained for 30
minutes at 37°C with 50 pi of a mixture containing 4 jIM ethidium
homodimer-1 (which stains dead cells) and 15 n Hoechst 33342
(which stains all cells). A minimum of six wells with two or three
randomly selected fields in each well was then examined using a
fluorescence microscope (Nikon). Each field of cells was photo-
graphed twice, once with a filter set for ethidium homodimer-1
(excitation A 525 nm, emission A 600 nm) and once with a filter set
for Hoechst 33342 (excitation A 340 nm, emission A 480 nm). The
number of dead cells per field was counted and normalized to the
control (which averaged 1 to 5 dead cells/field, <1% of the total
population). The statistical significance of these data were ascer-
tained using simple paired t-tests where appropriate or multiple
t-tests with a Bonferroni correction.
Results
Two different methods were used to monitor free radical
production in LLC-PK1 cells. One assay utilized nitroblue tetra-
zolium (NBT), a dye that is converted to a blue reaction in the
presence of superoxide [22—24]. The other assay utilized dihydro-
hodamine 123 (DHR), a nonfluorescent dye that is converted to a
fluorescent derivative (rhodamine 123, R 123) by free radicals
[25—27].
Studies using NBT indicated that oxalate exposure produces a
time and concentration-dependent increase in the accumulation
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0.0 Fig. 2. Effect of extracellular free radical scavengers on oxalate-induced
changes in NBT reduction. Experiments were performed as in Figure lB
B except that half of the samples received 500 U superoxide dismutase(SOD) along with the oxalate. Symbols are: (U) Ox; () Ox + SOD. SOD8 significantly reduced the effects of oxalate at all of the concentrations
tested (data are means SE from 9 to 20 determinations made on cells




.0 E 5 (Fig. 2), suggesting that this effect of oxalate was mediated by
E superoxide. Extracellular addition of catalase had no effect on
NBT reduction (data not shown).ON 4N Additional evidence for oxalate-induced changes in free radical
o cantly attenuated the oxalate-induced changes in NBT reduction
0 0 production were provided by studies using DHR 123 in which free
radical production was monitored "on-line" as an increase in
2 DHR fluorescence. These studies also demonstrated that oxalateproduces concentration-dependent increases in free radical pro-
1
duction (Fig. 3a). Significant increases in the rate of dye cleavage
were observed at oxalate concentrations  140 ILM free oxalate
________________
(P < 0.025), with 350 j.LM free oxalate increasing the rate0 ——
Control 0.35 m ox 0.75 m ox 1 .6 flM eightfold. The concentration dependent changes in free radicalproduction in oxalate-treated cells were mirrored by concentra-Treatment
tion-dependent increases in membrane damage as evidenced by
Fig. 1. Effect of oxalate on free radical production - NBT assay. A. Time the increased number of cells that took up vital dye (Fig. 3B).
dependence. In this representative experiment confluent monolayers of Significant increases in the number of dead (permeant) cells were
LLC-PK cells were exposed to DMEM containing 25 p.g/mI NBT plus observed at free oxalate concentrations  350 JLM free oxalate.
varying amounts of oxalate (0 to 4 m total, 0 to 1.6 m free). At the times
indicated (60, 90 120 or 240 mm) the medium was removed and samples To examine the apparent link between oxalate-induced in-
were processed as described in the text. The amount of blue reaction creases in free radicals and cell injury, we assessed the effects of
product was quantitated in a spectrophotometer by measuring the absor- various free radical scavengers on free radical production (mon-
bance at 700 nm (0D700). Data are means su for 6 wells. B. itored as an increase in DHR fluorescence) and cell death
Concentration dependence. Confluent monolayers of LLC-PK1 cells were
exposed to DMEM containing 25 g/ml NBT plus varying amounts of (detected as an increase in staining by vital dyes). Simultaneous
oxalate (0 to 1.6 m free) for 90 minutes and the extent of NBT reduction addition of catalase, an enzyme that degrades peroxide, or
was assessed. Data reflect means SE from 28 to 44 determinations made superoxide dismutase, an enzyme that converts superoxide to
on cells from 7 separate platings; analysis employed multiple f-tests with a peroxide, significantly reduced the effect of oxalate on DHR
Bonferroni correction to determine significance; hence * < 0.00167. fluorescence and on cell death (Table 1). Moreover, pretreatment
Symbols are: (A) control; (•) 0.35 msi Ox; (A) 0.75 mivi Ox; (U) 1.6 mM. with desferoxamine, an iron chelator, or mannitol, a hydroxyl
radical scavenger, significantly reduced oxalate toxicity (Table 1).
Treatment with citrate, a metabolite that affords protection from
of reduced dye (Fig. 1), with significant increases seen after 90 stone formation in vivo [29] produced modest effects on free
minutes exposure to free oxalate concentrations  0.35 mrvi (Fig. radical production (28% reduction) due perhaps to its ability to
1B, lower concentrations not tested in this assay) [281. Extracel- inhibit dye peroxidation [301 but afforded no protection from
lular addition of superoxide dismutase (SOD, 500 U/mi) signifi- oxalate-inducd changes in membrane integrity (Table 1).
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Fig. 3. Parallel effects of oxalate on free radical production and cell death in
LLC-PK1 cells. A. Oxalate-induced changes in free radical production
were assessed by monitoring the cleavage of dihydrorhodamine 123
(DHR) to rhodamine 123. Confluent monolayers of LLC-PK1 cells were
loaded with DHR 123 for two minutes; the basal rate of DHR cleavage
was determined and then varying concentrations of oxalate (30, 140 or 350
/LM free oxalate) were added. The rate of change in DHR fluorescence(the slope of the fluorescence trace) was taken as an estimate of the rate
of free radical production. Oxalate () produced a concentration-depen-
dent increase in DHR cleavage, with significant increases seen at concen-
trations 140 M. Data are means SEM from 6 to 10 monolayers;
statistical significance was assessed using paired t-tests. B. Oxalate-induced
changes in cell death. LLC-PK1 cells were exposed to varying concentra-
tions of oxalate (30, 140 or 350 rM oxalate) for four hours and then stained
with a combination of vital dyes (Hoechst 33342 which is taken up by all
cells and ethidium-homodimer 1 which is taken up only by dead cells).
Oxalate exposure produced a concentration dependent increase in the
average number of dead (ethidium-stained) cells, with significant increases
seen at concentrations  0.35 m. Data are means SE from 9 to 25
separate monolayers; analysis employed multiple 1-tests with a Bonferroni
correction to determine significance; hence * < 0.0125.
Table 1. Effect of free radical scavengers on oxalate-induced changes in
cell death and in DHR fluorescence
Treatment Deaths/fielda % Oxalate DHR response"
Oxalate 14.6 1.93 (N = 46) 100 (N = 11)
Oxalate + catalase 6.75 1.39 (N = 34)C 51.4 19.5 (N = 19)C
Oxalate + SOD 5.75 0.92 (N = 18)C 43.3 16.6 (N = 14)C
Oxalate + DFO 9.53 1.47 (N = 21)C ND
Oxalate + mannitol 2.99 0.98 (N = 9)C 63.8 7.0 (N = 3)C
Oxalate + citrate 10.45 2.06 (N = 18) 64.2 9.0 (N = 6)C
ND is not determined.
a Each culture was exposed to 350 jrM free oxalate (1 m total)
additive for 4 hr and then stained with vital dyes. Stained cells were
counted in 2 or 3 random fields from each culture and the average was
corrected for spontaneous cell death (that is, that which occurred in
untreated control cultures). Where indicated, cultures were exposed to
catalase (500 U/mI), superoxide dismutase (SOD, 400 U/ml) or mannitol(10 or 60 mM) for 4 hr. Cultures treated with DFO (desferoxamine
mesylate) were preincubated for 1 hr with 20 mivi DFO prior to oxalate
addition. Data reflect mean SEM deaths/field in 18 to 46 cultures.
"For each experimental series, the average response to 350 jrM free
oxalate (ie the average rate of cleavage of DHR) was determined and used
to normalize other treatment groups from that series. Where indicated
catalase (500 U/mI), superoxide dismutase (400 U/mI) or mannitol (10
mM) was added along with oxalate. Data reflect mean SEM % inhibition
of oxalate-induced DHR fluorescence from 3 to 14 cultures.























responses to formate (both with respect to free radical production
and cell death) were less than half produced by oxalate. Exposure
to citrate had no effect on free radical production (Fig. 4A) or on
cell viability (data not shown). Exposure to urate (0.8 to 2 mM),
another crystal-forming molecule, produced produced no changes
in cellular viability. Effects of urate on DHR cleavage have not
been assessed.
Discussion
The present studies provide compelling evidence that exposure
to oxalate increases the production or availability of free radicals
in renal epithelial cells. This was demonstrated using two separate
asssays: (1) the reduction of nitroblue tetrazolium to a blue
reaction product, a process that is mediated by superoxide [22—
24], (2) the cleavage of DHR 123 to a fluorescent derivative, a
process that is also mediated by reactive oxygen molecules
[25—27]. The oxalate-induced increase in free radical production
was mirrored by an increase in the number of damaged cells in the
monolayers. Indeed, these two effects of oxalate, increased free
radical production and cell death, appeared to be linked in that
both responses showed a similar concentration dependency and a
similar sensitivity to free radical scavengers.
Of the various mono- and dicarboxylates examined in the
present studies, oxalate was the most potent at increasing free
radical production and cell death. Formate, which shares the
oxalate transporter on the apical surface of renal brush border
membranes [6, 8] also increased DHR cleavage and increased the
incidence of dead cells in the LLC-PK1 cultures; however, the
effects on both parameters was less than half that produced by
comparable levels of oxalate. Other structurally related molecules
(malonate, succinate, citrate) produced modest increase in free
radical production with no effect on cell viability.
The precise sequence of events by which oxalate increases free
radical production/availability remains unknown. The effects are
presumably secondary to oxalate entry into the cells since oxalate
The observed increase in free radical production and in cell
death appeared to be relatively selective for oxalate. Other mono-
and dicarboxylates produced much more modest increases in free
radical production (monitored using DHR cleavage fluorescence;
Fig. 4A) and minimal effects on cell viability (Fig. 4B). The effects
of 1 ms malonate or 1 mtvi succinate on free radical production
were approximately half that seen in response to equimolar
addition of oxalate, comparable to those produced by 0.1 m total
oxalate (Fig. 3A). These increases in free radical production, like
those produced by 0.1 mrvi oxalate (Fig. 3B) failed to increase cell
death. Only formate, which shares the oxalate transporter in the
kidney [6, 8], produced a significant increase in both free radical
production and cell death in LLC-PK1 monolayers; and the
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Fig. 4. Specificity of oxalate-induced changes in free radical production and
cell death. A. Free radical production. The rate of cleavage of DHR was
assessed as described above after the addition of structurally related
mono- and dicarboxylic acids (1 m total in all cases). Note that the
oxalate-induced changes in free radical production were considerably
higher than those produced by other compounds. Data are means SEM
from 4 to 10 monolayers for each analogue; P < 0.01 for all additives
except citrate. B. Cell death. Cells were exposed to various additives
(added at 1 mM) for four hours and stained with vital dyes. Of the
compounds tested, only oxalate and formate induced significant increases
in the number of dead cells Data are means SEM from 6 (malonate,
succinate, urate) or 29 (formate) monolayers.
added in solution had no effect on DHR fluorescence. (The
requirement for oxalate uptake could not be tested directly,
however; since LLC-PK1 cells are adversely affected by treatments
that inhibit oxalate transport such at exposure to stilbene deriva-
tives and/or to bicarbonate free buffers, data not shown). Once
inside the cells, oxalatc could increase free radical production in
a number of ways: (1) by acting as a precursor in the generation
of a reactive metabolite, (2) by altering mitochondrial function,
(3) by modifying the activities of various cytosolic enzymes that
generate reducing equivalents, (4) by inhibiting endogenous free
radical scavenging enzymes. Of these possibilities, several are
inconsistent with available data. For example, it seems unlikely
that free radicals are produced as a byproduct of oxalate metab-
olism since animal cells lack the requisite enzymatic machinery for
oxalate degradation. Similarly, it seems unlikely that the increase
in free radicals reflects direct effects on mitochondrial metabolism
since our previous studies on isolated mitochondria revealed no
oxalate-induced changes in respiration, ATP production, or trans-
membrane calcium fluxes [31]. Oxalate could alter mitochondrial
metabolism indirectly, however, by altering cytosolic enzymes that
supply substrates to mitochondria. Such a possibility is supported
by in vitro evidence for inhibitory effects of oxalate on a number of
cytosolic enzymes including lactate dehydrogenase, pyruvate ki-
nase and malonate dehydrogenase [10]. Alternatively or in addi-
tion, oxalate may increase the availability of free radicals by
inhibiting enzymes responsible for their degradation. This possi-
bility was suggested by preliminary studies indicating that oxalate
can inhibit peroxidase activity in vitro (Koul, unpublished results).
Whatever the initiating event, exposure to oxalate appears to
increase the levels of superoxide within cells. Subsequent reac-
tions within the LLC-PK1 cells lead to the production of other
reactive species including peroxide and hydroxyl radicals by a
process that is dependent at least in part on iron. Support for this
scenario includes the finding that extracellular addition of super-
oxide dismutase (which converts superoxide to peroxide and
oxygen), catalase (which degrades peroxide), desferoxamine
(which chelates iron) and mannitol (which scavenges hydroxyl
radicals) all reduced oxalate toxicity.
Other potential mechanisms for oxalate toxicity (such as free
radical-independent pathways) were also considered. Possible
effects of oxalate on intracellular calcium or intracellular pH were
excluded in previous studies [16, 32]. A role for calcium oxalate
crystals in oxalate action could not be excluded, however. Bire-
fringent calcium oxalate crystals were observed in our oxalate
containing buffers, and evidence from other studies has suggested
that calcium oxalate crystals can induce damage to cellular
membranes [33—35]. Moreover, recent studies on endothelial cells
have demonstrated that the endocytosis of crystals can increase
free radical production [22]. Thus effects mediated by crystals may
have contributed to the observed responses in LLC-PK1 cells. No
obvious link between crystal adherence and damage was detected
in the present studies, however. Some damaged cells were asso-
ciated with crystals, most were not. Further studies will be
required to define the actions of calcium oxalate crystals on renal
epithelial cells.
Oxalate toxicity was only observed at free oxalate concentra-
tions  350 .LM, somewhat higher than might be expected to occur
within the proximal tubules. Oxalate levels in normal individuals
average only 5 to 10 jx in the glomerular filtrate [36] rising
-10-fold by the end of the proximal tubule as fluid is reabsorbed.
Levels of oxalate in this region may be increased further by net
secretion of oxalate [2, 4], but the final concentration of oxalate
that is achieved has not been determined due to limitations with
current oxalate assays. Current estimates of regional oxalate levels
have been made by assuming oxalate exchange mimics that of
other metabolites (ignoring net oxalate secretion). Alternatively
estimates have been derived from measurements on lyophilized
samples [37]. Thus it is not clear whether oxalate would ever reach
toxic levels in the proximal tubules of normal kidneys; however,
toxic levels might well occcur in individuals with chronically
elevated oxalate levels.
Taken together these results indicate that oxalate can no longer
be considered an inert metabolic end product. Our studies suggest
that even modest increases in urinary oxalate levels may have
serious consequences for renal function and contribute to the
progression/severity of several forms of renal disease. For exam-
ple, oxalate-induced damage to proximal tubular cells could
promote stone formation by providing cellular debris for crystal
nucleation and aggregation and by enhancing crystal binding to
other tubular cells. This scenario is supported by several lines of
evidence: (1) tubular damage (enzymuria and membranuria) has
been observed both in clinical [38] and experimental [39, 40] stone
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with nephrotoxic doses of gentamicin) increase the incidence of
plaques and stones in experimental animals [41]; (3) conditions
that disrupt renal epithelial polarity in vitro (disruption of tight
junctions with Ca2 chelators) promote crystal binding [42]; (4)
addition of membrane fractions from renal tubular cells promotes
the growth of calcium oxalate crystals in artificial urine [43]. These
considerations provide a compelling argument for a role of
oxalate toxicity in the pathogenesis of calcium oxalate stone
disease. Oxalate toxicity may also contribute to the progression of
end-stage renal disease [44, 45]. Hyperoxalemia is a common
feature in end-stage renal disease and a number of investigators
have suggested the importance of reducing the oxalate burden in
these individuals [44, 45]. Clearly, additional investigations as to
the clinical significance of hyperoxaluria and hyperoxalemia and
methods for reducing oxalate toxicity in vivo are warranted.
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